Related Experiment Video
Updated: Nov 5, 2025

A Quantitative Detection Method for MicroRNAs in the Kidney of an Ischemic Kidney Injury Mouse Model
Published on: September 11, 2020
MicroRNA in Human Acute Kidney Injury: A Systematic Review Protocol
Adrianna Douvris1, Dylan Burger1,2, Rosendo A Rodriguez3
1Division of Nephrology, Department of Medicine and Kidney Research Centre, Ottawa Hospital Research Institute, The University of Ottawa and The Ottawa Hospital, ON, Canada.
Background:
Acute kidney injury (AKI) is a common complication of hospitalization with high morbidity and mortality for which no effective treatments exist and for which current diagnostic tools have limitations for earlier identification. MicroRNAs (miRNAs) are small non-coding RNAs that have been implicated in the pathogenesis of AKI, and some miRNAs have shown promise as therapeutic tools in animal models of AKI. However, less is known about the role of miRNAs in human AKI.
Objective:
To evaluate the role of miRNAs in human subjects with AKI.
Design:
Systematic review and meta-analysis.
Measurements:
Quantification of miRNA levels from human blood, urine, or kidney biopsy samples, and measures of renal function as defined in the study protocol.
Methods:
A comprehensive search strategy for Ovid MEDLINE All, Embase, Web of Science, and CENTRAL will be developed to identify investigational studies that evaluated the relationship between miRNA levels and human AKI. Primary outcomes will include measurements of kidney function and miRNA levels. Study screening, review and data extraction will be performed independently by 2 reviewers. Study quality and certainty of evidence will be assessed with validated tools. A narrative synthesis will be included and the possibility for meta-analysis will be assessed according to characteristics of clinical and statistical heterogeneity between studies.
Limitations:
These include (1) lack of randomized trials of miRNAs for the prevention or treatment of human AKI, (2) quality of included studies, and (3) sources of clinical and statistical heterogeneity that may affect strength and reproducibility of results.
Conclusion:
Previous studies of miRNAs in different animal models of AKI have generated strong interest on their use for the prevention and treatment of human AKI. This systematic review will characterize the most promising miRNAs for human research and will identify methodological constraints from miRNA research in human AKI to help inform the design of future studies.
Systematic Review Registration:
PROSPERO CRD42020201253.
Insights
This systematic review evaluates microRNAs (miRNAs) in human acute kidney injury (AKI). It identifies promising miRNAs and research constraints to guide future studies on AKI prevention and treatment.
Area of Science:
- Biochemistry
- Molecular Biology
- Nephrology
Background:
- Acute kidney injury (AKI) is a significant cause of hospitalization with high mortality and limited treatment options.
- Current diagnostic tools for AKI have limitations in early identification.
- MicroRNAs (miRNAs) are implicated in AKI pathogenesis, with potential therapeutic roles shown in animal models, but their role in human AKI is less understood.
Purpose of the Study:
- To systematically review and analyze the role of microRNAs (miRNAs) in human subjects diagnosed with acute kidney injury (AKI).
- To identify specific miRNAs that show promise for research in human AKI.
- To highlight methodological limitations in current miRNA research concerning human AKI.
Main Methods:
- A systematic review and meta-analysis approach was employed.
- A comprehensive literature search was conducted across multiple databases (Ovid MEDLINE All, Embase, Web of Science, CENTRAL).
- Studies quantifying miRNA levels in human samples (blood, urine, kidney biopsy) and measuring renal function were included; study quality and heterogeneity were assessed.
Main Results:
- The review will characterize promising miRNAs for human AKI research.
- Methodological constraints in current miRNA research for human AKI will be identified.
- The potential for meta-analysis will be assessed based on study heterogeneity.
Conclusions:
- There is a lack of randomized trials investigating miRNAs for human AKI prevention or treatment.
- The quality of included studies and sources of heterogeneity pose challenges to the strength and reproducibility of findings.
- This review aims to inform future research design by identifying key miRNAs and methodological constraints in human AKI miRNA studies.
More Related Videos
Related Concept Videos
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury VI: Nursing Management

